页码 截至 2023 年 6 月 30 日前次募集资金使用情况报告 1-8 鉴证报告 西安凯立新材料股份有限公司 載至 2023 年 6 月 30 日 前次募集资金使用情况鉴证报告 索引 t the sub 北京市东城区朗阳门北大街 关于西安凯立新材料股份有限公司 前次募集资金使用情况鉴证报告 XYZH/2023BJAA11F0288 西安凯立新材料股份有限公司全体股东: 我们对后附的西安凯立新材料股份有限公司(以下简称"凯立新材")于2021年6月募 集的人民币普通股资金（以下简称前次募集资金）截至2023年6月30日止的使用情况报告 (以下简称《前次募集资金使用情况报告》）执行了鉴证工作。 凯立新材董事会的责任是按照中国证券监督管理委员会、上海证券交易所相关规定编 制前次募集资金使用情况报告。这种责任包括设计、实施和维护与前次募集资金使用情况 报告编制相关的内部控制,保证前次募集资金使用情况报告的真实、准确和完整,以及不 存在由于舞弊或错误而导致的重大错报。我们的责任是在实施鉴证工作的基础上,对前次 募集资金使用情况报告发表鉴证意见。 我们按照《中国注册会计师其他鉴证业务准则第3101号―历史财务信息审计 ...

证券代码：688269 证券简称：凯立新材 公告编号：2023-036 西安凯立新材料股份有限公司 2023 年半年度募集资金存放与使用情况的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 西安凯立新材料股份有限公司(以下简称"凯立新材""本公司"或"公司") 董事会根据《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要 求》《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上市公司自 律监管指引第 1 号——规范运作》等相关规定，对 2023 年半年度募集资金存放与 使用情况作如下专项报告： 一、募集资金基本情况 （一）募集资金管理制度情况 （一）募集资金金额和资金到账时间 根据中国证券监督管理委员会出具的《关于同意西安凯立新材料股份有限公司 首次公开发行股票注册的批复》（证监许可［2021］1396 号），公司首次公开发 行人民币普通股（A 股）2,336.00 万股，募集资金总额人民币 442,438,400.00 元，扣除与发行有关的费用（不含税）人民币 41,856,819.51 ...

证券代码：688269 证券简称：凯立新材 公告编号：2023-037 西安凯立新材料股份有限公司 前次募集资金使用情况的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 西安凯立新材料股份有限公司 截至 2023 年 6 月 30 日止 关于前次募集资金使用情况报告 西安凯立新材料股份有限公司（以下简称"本公司""公司"）董事会编制了本公司 于2021年6月募集的人民币普通股资金截至2023年6月30日止的使用情况报告（以下简称 《前次募集资金使用情况报告》）。 一、前次募集资金基本情况 （一）前次募集资金金额和资金到账时间 根据中国证券监督管理委员会出具的《关于同意西安凯立新材料股份有限公司首次公 开发行股票注册的批复》（证监许可［2021］1396 号），公司首次公开发行人民币普通股 （A 股）2,336.00 万股，募集资金总额人民币 442,438,400.00 元，扣除与发行有关的费 用（不含税）人民币 41,856,819.51 元，募集资金净额为人民币 400,581,580.49 元。上 述资金已 ...

Kaili Catalyst & New Materials Co.,Ltd. （西安经济技术开发区泾渭新城泾勤路西段 6 号） 关于西安凯立新材料股份有限公司 向特定对象发行股票申请文件 的第二轮审核问询函之回复 保荐人（主承销商） 二〇二三年八月 7-1-1 上海证券交易所： 贵所于 2023 年 8 月 2 日出具的《关于西安凯立新材料股份有限公司向特定对象发 行股票申请文件的第二轮审核问询函》（上证科审（再融资）〔2023〕190 号）（以下 简称"审核问询函"）已收悉。西安凯立新材料股份有限公司（以下简称"凯立新材"、 "发行人"、"公司"）与中信建投证券股份有限公司（以下简称"中信建投证券"、 "保荐人"、"保荐机构"）、国浩（西安）律师事务所（以下简称"发行人律师"） 等相关方，本着勤勉尽责、诚实守信的原则，就审核问询函所提问题逐条进行了认真讨 论、核查和落实，现回复如下，请予审核。 关于回复内容释义、格式及补充更新披露等事项的说明： 1、如无特殊说明，本审核问询函回复中使用的简称或名词释义与《西安凯立新材 料股份有限公司 2023 年度向特定对象发行 A 股股票募集说明书》（以下简称"募集说 ...

国浩律师（西安）事务所 补充法律意见书（二） 国浩律师（西安）事务所 关于 西安凯立新材料股份有限公司 向特定对象发行股票 之 补充法律意见书（二） 西安市雁塔区绿地中心 B 座 46 层 邮编：710065 The 46th Floor, Block B, Xi'an Greenland Center, Yanta District, Xi'an 710065,China 电话/Tel: +86 29 8819 9711 网址/Website: http://www.grandall.com.cn 2023 年 8 月 国浩律师（西安）事务所 补充法律意见书（二） 国浩律师（西安）事务所 关于西安凯立新材料股份有限公司 向特定对象发行股票之 补充法律意见书（二） 致：西安凯立新材料股份有限公司 国浩律师（西安）事务所（以下简称"本所"）接受西安凯立新材料股份有 限公司（以下简称"发行人"）的委托，根据《中华人民共和国证券法》《中华 人民共和国公司法》《上市公司证券发行注册管理办法》《上海证券交易所科创 板股票上市规则》等法律、法规和中国证券监督管理委员会的有关规定，按照《律 师事务所从事证券法律业务管理办法 ...

证券代码：６８８２６９ 证券简称：凯立新材 公告编号：2023-034 西安凯立新材料股份有限公司 关于向特定对象发行股票申请文件的 第二轮审核问询函回复的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 1 2023 年 8 月 2 日，西安凯立新材料股份有限公司（以下简称"公司"）收 到上海证券交易所（以下简称"上交所"）出具的《关于西安凯立新材料股份有 限公司向特定对象发行股票申请文件的第二轮审核问询函》（上证科审（再融资） 〔2023〕190 号）（以下简称"审核问询函"）。 特此公告。 公司收到审核问询函后，按照要求会同相关中介机构就审核问询函提出的问 题进行了认真研究和逐项落实，现根据相关要求对审核问询函回复进行公开披 露，具体内容详见公司同日在上海证券交易所网站（www.sse.com.cn）披露的《关 于西安凯立新材料股份有限公司向特定对象发行股票申请文件的第二轮审核问 询函之回复》等文件，公司将按照要求及时将回复材料报送上海证券交易所。 西安凯立新材料股份有限公司董事会 公司本次向特定对象发行 ...

证券代码：688269 证券简称：凯立新材 公告编号：2023-028 西安凯立新材料股份有限公司 关于参加 2022 年度先进金属材料专场 集体业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依 法承担法律责任。 重要内容提示： 会议线上交流时间：2023 年 5 月 24 日(星期三)下午 14:00-16:00 会议召开方式：视频和线上文字互动 视频和线上文字互动平台：上海证券交易所上证路演中心（网址： http://roadshow.sseinfo.com/） 投资者可于 2023 年 5 月 22 日(星期一)17:00 前将问题发送至公司 投资者关系邮箱（zhengquanbu@xakaili.com），公司将在文字互动环 节对投资者普遍关注的问题进行回答。 西安凯立新材料股份有限公司（以下简称"公司"）已于 2023 年 3 月 25 日发布公司 2022 年年度报告，为便于广大投资者更全面深入 地了解公司 2022 年度经营成果、财务状况、发展理念，公司参与了 由上交所主办的 2022 年度先进金属材料专场集 ...

证券代码：688269 证券简称：凯立新材 公告编号：2023-023 西安凯立新材料股份有限公司 关于参加"2023 年陕西辖区上市公司投资者集体接待日 暨 2022 年度业绩说明会"的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依 法承担法律责任。 重要内容提示： 特此公告。 西安凯立新材料股份有限公司董事会 届时，公司董事长张之翔先生，董事会秘书兼财务总监王世红女 士,独立董事王周户先生（如有特殊情况，参会人员可能进行调整） 会议召开时间：2023 年 5 月 16 日 15:00-17:00。 会议召开地点："全景路演"；网址：http://rs.p5w.net。 会议召开方式：网络互动。 将通过互动平台与投资者进行网络沟通和交流，欢迎广大投资者踊跃 参加！ 活动时间：2023 年 5 月 16 日 15:00-17:00。 活动地址："全景路演" 网址：http://rs.p5w.net。 投资者问题征集渠道：投资者可于 2023 年 5 月 12 日 17:00 前访 问网址 https://ir.p5w.net/zj， ...

Financial Performance - The company's operating revenue for Q1 2023 was CNY 494,523,598.30, representing a year-on-year increase of 57.61%[2] - The net profit attributable to shareholders decreased by 25.77% to CNY 41,259,946.58 compared to the same period last year[2] - The net profit for Q1 2023 was CNY 41,259,946.58, a decrease of 25.8% compared to CNY 55,584,727.42 in Q1 2022[13] - The net profit for Q1 2023 was CNY 38.20 million, down 30.7% from CNY 55.19 million in Q1 2022[25] - The total revenue from operating activities was CNY 275,658,026.08, up from CNY 229,521,513.95 in the same period last year, representing a growth of 20.1%[16] - The company reported a total comprehensive income of CNY 40,854,418.90 for Q1 2023, down from CNY 55,414,167.39 in Q1 2022, reflecting a decline of 26.4%[14] - Basic and diluted earnings per share for Q1 2023 were both CNY 0.32, compared to CNY 0.43 in Q1 2022, indicating a decrease of 25.6%[14] Cash Flow and Liquidity - The net cash flow from operating activities was negative at CNY -112,997,488.09, a significant decline of 2,906.47% year-on-year[2] - The cash flow from operating activities showed a net outflow of CNY 112,997,488.09, compared to a net inflow of CNY 4,026,322.32 in Q1 2022[17] - The cash flow from operating activities showed a net outflow of CNY 180.16 million, compared to a net outflow of CNY 7.79 million in Q1 2022[27] - The company's cash and cash equivalents decreased to RMB 301,292,707.00 from RMB 460,316,208.73 as of December 31, 2022, representing a decline of 34.6%[9] - The cash and cash equivalents at the end of Q1 2023 were CNY 300,962,707.00, down from CNY 374,384,787.32 at the end of Q1 2022[18] - The net increase in cash and cash equivalents was -$197,827,009.22, indicating a significant cash outflow[28] - The initial cash and cash equivalents balance was $420,379,880.64, showing a decline in liquidity[28] - The impact of exchange rate changes on cash and cash equivalents was -$4,728.15, reflecting currency fluctuations[28] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,530,057,133.64, a slight increase of 0.05% from the end of the previous year[3] - The total assets amounted to CNY 1,418.28 million, slightly down from CNY 1,420.84 million in the previous quarter[22] - The company's total liabilities decreased to RMB 519,359,629.12 from RMB 559,373,956.00, a reduction of 7.1%[11] - The total liabilities decreased to CNY 430.17 million from CNY 470.52 million in the previous quarter, indicating a reduction of 8.6%[22] - The total liabilities as of March 31, 2023, were CNY 1,035,399,196.30, a slight decrease from CNY 1,058,414,311.33 at the end of 2022[20] Research and Development - Research and development expenses totaled CNY 13,542,325.31, accounting for 2.74% of operating revenue, a decrease of 0.91 percentage points year-on-year[3] - Research and development expenses for Q1 2023 were RMB 13,542,325.31, up from RMB 11,460,520.14 in Q1 2022, reflecting a growth of 18.2%[12] - Research and development expenses increased to CNY 13.54 million, up from CNY 11.46 million in the same period last year, reflecting a growth of 18.2%[24] Market and Growth Strategy - The company reported a significant increase in multi-phase product revenue, which rose by 48.20% year-on-year, while the revenue from pharmaceutical and chemical new materials grew by 46.29% and 123.01%, respectively[5] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[5] Profitability - The weighted average return on equity was 4.17%, down by 2.22 percentage points compared to the previous year[3] - The gross profit margin for catalyst products decreased due to a higher proportion of lower-margin sales, impacting overall profitability[5]

Financial Performance - The company's operating revenue for 2022 was CNY 1,882.20 million, representing an increase of 18.43% compared to CNY 1,589.33 million in 2021[23]. - The net profit attributable to shareholders for 2022 was CNY 221.11 million, a growth of 36.02% from CNY 162.56 million in 2021[23]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 213.71 million, up 48.87% from CNY 143.56 million in 2021[23]. - The net cash flow from operating activities for 2022 was CNY 98.10 million, a significant increase of 105.20% compared to CNY 47.81 million in 2021[23]. - The total assets at the end of 2022 were CNY 1,529.22 million, reflecting a 32.33% increase from CNY 1,155.58 million at the end of 2021[23]. - The net assets attributable to shareholders at the end of 2022 were CNY 969.84 million, an increase of 15.18% from CNY 842.03 million at the end of 2021[23]. - The basic earnings per share for 2022 were CNY 1.69, up 19.01% from CNY 1.42 in 2021[24]. - The diluted earnings per share for 2022 were also CNY 1.69, consistent with the basic earnings per share[24]. - The company achieved a main business revenue of 1,849.34 million RMB, a year-on-year increase of 17.03%[102]. - The net profit attributable to shareholders was 221.11 million RMB, reflecting a growth of 36.02% compared to the previous year[102]. - Operating income increased by 18.43% to 1,882.20 million RMB, while operating costs rose by 15.81% to 1,543.99 million RMB[103]. Research and Development - The R&D investment as a percentage of operating revenue was 3.03% in 2022, a slight decrease from 3.18% in 2021[24]. - The total R&D investment for the year was CNY 57.12 million, an increase of 12.89% compared to the previous year, representing 3.03% of total revenue[63]. - The company invested RMB 57.12 million in research and development during the reporting period, resulting in 28 new patents, including 27 invention patents[34]. - The company has established a research and development model that combines independent research with collaborative efforts, focusing on both short-term and long-term scientific goals[41]. - The company is actively engaged in the research and development of new catalyst technologies to address industry challenges and enhance its competitive edge[42]. - The company has developed various catalysts, including mercury-free PVC catalysts, fuel cell catalysts, and hydrogen production catalysts, enhancing its product range and application fields[54]. - The company has developed a green synthesis process for platinum-carbon catalysts used in fuel cells, completing the transition from laboratory trials to kilogram-level batch production in 2022[136]. - The company is focusing on reducing the amount of precious metals in catalysts while maintaining performance, leading to the development of high-quality low-content precious metal catalysts[135]. Profit Distribution and Dividends - The company plans to distribute a cash dividend of 7.00 RMB per 10 shares, totaling approximately 91.49 million RMB (including tax) based on a total share capital of 130,704,000 shares as of December 31, 2022[5]. - The board of directors has approved the profit distribution plan, pending shareholder meeting approval[5]. - The company has not implemented any capital reserve transfers or stock dividends in its profit distribution plan[5]. - The cash dividend distribution for 2022 is based on the total share capital at the time of the rights distribution[200]. - The company aims to maintain a stable profit distribution policy while considering sustainable development and investor returns[198]. - The company's profit distribution decision-making process involves management, the board of directors, and requires approval from the shareholders' meeting[199]. Governance and Compliance - The governance structure includes a clear division of responsibilities among the shareholders' meeting, board of directors, and supervisory board, ensuring compliance with relevant laws and regulations[164]. - The board of directors has established various committees, including a strategy committee, audit committee, and compensation and assessment committee, to enhance governance effectiveness[164]. - The company has implemented a series of governance systems and continuously revises them according to regulatory requirements, ensuring a coordinated and balanced governance structure[165]. - The company has not faced any penalties from securities regulatory agencies in the past three years, indicating compliance with regulations[184]. Market and Strategic Development - The company is focusing on diversifying its technology service models, which has led to increased technical service revenue[112]. - The company is committed to developing new markets and users, adhering to the dual circulation strategy to boost international market development and grow into a renowned international enterprise[162]. - The company aims to enhance its catalyst performance and develop specialized catalysts to meet customer needs, thereby driving stable growth in catalyst sales[39]. - The company is actively expanding into new fields such as basic chemicals and environmental new energy, with multiple new products and technologies launched during the reporting period[50]. - The company is committed to achieving carbon neutrality goals by developing catalysts for industrial wastewater treatment and air purification, as well as hydrogen fuel cell applications[160]. Operational Efficiency and Production - The company is enhancing collaboration with domestic universities and research institutions to bolster its technological innovation strategy[158]. - Continuous optimization of production processes is emphasized, including automation and intelligent upgrades to improve stability, continuity, and scale of production, thereby enhancing market efficiency and product quality while reducing costs[162]. - The company has established a complete R&D and production service industry chain, enhancing its innovation-driven development model[92]. - The company is committed to enhancing the efficiency of its production processes, including the recovery and purification of precious metals from waste catalysts[139]. Customer and Supplier Relations - The company serves nearly 1,000 downstream customers, including over 100 A-share listed companies, indicating a large and high-quality user base[48]. - The top five customers contributed sales of 66,608.44 million yuan, accounting for 36.02% of total annual sales, with customer E becoming a new major client due to increased demand for homogeneous catalysts[113][114]. - The top five suppliers accounted for 91,755.59 million yuan in purchases, representing 54.32% of total annual procurement, with suppliers D and E added to the list due to their timely supply capabilities[115][119]. Investment and Financial Strategy - The company plans to apply for comprehensive credit financing from domestic banks for the year 2022, indicating a strategy for financial support and growth[166]. - The company has made a total investment of RMB 8,613 million in external equity investments during the reporting period, with significant investments in Xi'an Younait and Tongchuan Kaili[151]. - The company is exploring potential mergers and acquisitions to enhance its technological capabilities and market presence[173].